Galectin-3: A Therapeutic Target for Cancer and Tissue Fibrosis
Researchers at the University of Liverpool have discovered two synthetic compounds as strong galectin-3 binding inhibitors.
Published: 28th September 2020
Researchers at the University of Liverpool have discovered two synthetic compounds as strong galectin-3 binding inhibitors.